Article info
PDFHepatology
Original article
Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus
- Correspondence to Dr Gino Miele, genedrive plc, Manchester, UK; g.miele{at}genedrive.com and Darragh Duffy, Immunobiology of Dendritic Cells, Institut Pasteur, Paris 75015, France; darragh.duffy{at}pasteur.fr
Citation
Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus
Publication history
- Received November 30, 2017
- Revised March 9, 2018
- Accepted March 14, 2018
- First published April 3, 2018.
Online issue publication
April 03, 2019
Article Versions
- Previous version (3 April 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/